A Study to Evaluate Safety and Efficacy of Infliximab in Chinese Participants With Moderate to Severe Plaque-type Psoriasis
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the superiority and efficacy of infliximab
induction therapy in chinese participants with moderate to severe plaque-type psoriasis
(scaly skin rash) compared with placebo (an inactive substance that is compared with a drug
to test whether the drug has a real effect in a clinical trial).